Chongqing Pharscin Pharmaceutical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Chongqing Pharscin Pharmaceutical — overview

Assets Under Management

Type

Corporate Investor

Location

Chongqing China

Alternative Asset Classes

PEVCRE

About

Listed on the Shenzhen Stock Exchange in 2017, Chongqing Pharscin Pharmaceutical is a China-based corporate investor that engages in medicine research and development, manufacturing as well as retail.

Chongqing Pharscin Pharmaceutical - known decision makers (5)

Contact NamePositionLocationEmailTelephoneAsset Class
Chief Executive Officer & Board DirectorChongqing, ChinaPERE
Founder & ChairmanChongqing, ChinaPERE
Director & Deputy general managerChongqing, ChinaPERE
Director & Secretary of the Board & Deputy General ManagerChongqing, ChinaPERE
Chief financial officerChongqing, ChinaPERE

Showing 5 of 5 known decision makers Chongqing Pharscin Pharmaceutical

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.